Table: begin end state 1 50 cytoplasmic 51 72 transmembrane 73 190 non-cytoplasmic 191 192 cytoplasmic 193 196 non-cytoplasmic 197 220 transmembrane 221 231 non-cytoplasmic 232 265 transmembrane 266 280 cytoplasmic 281 304 transmembrane 305 330 non-cytoplasmic 331 349 transmembrane 350 378 cytoplasmic 379 399 transmembrane 400 410 non-cytoplasmic 411 441 transmembrane 442 443 non-cytoplasmic 444 446 cytoplasmic 447 469 transmembrane 470 474 cytoplasmic 475 481 non-cytoplasmic
Input: >WP_058932742.1 NCBI__GCF_001484605.1:WP_058932742.1 MRPPTCRKHHHPSRDVCSGCNGASLATPPKWRIFILRSTPKGSPHRRPGGLLKVIGAVFA SVVAILLVVAPASQATSPSPTPSPSITTFQNNISGFLRDDARAPIADVTITARSGDFEGT ATSAANGSWSIGVPVQGTYEIELDESTLPEGIKLAEGQENPRSVTFSQTSNLSVIFAFGE GIVVQQQDFGQNLVNRLVAGLSFGLLLALASVGLSLIFGTTGLTNFAHGEMVTLGAVLVF AFNAIGLPFWLALILSLLGGGLFGYIQDAGLWKPLRRRGTGLVPMMIVSIGLALAVRYVI QFYFGGATQQLPFAQSAEIQLGPISISPNNLWSLIVSAVVIALLGIVLLKTRLGKATRAV ADNPALAAASGIDVDSVIRIVWVTGGMLASLGGILWAYYRPGVTFDMGSQILLLIFAGVT LGGLGTVFGALIGSIIVGIFVELTTVFGLAADLKYVGALFIMIVVLLFRPQGILGRRERV G
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server